0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global glycosylated biosimilars market research report 2019.Your search for "" gave back 1533495 results.
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
The global Interferon Biosimilar market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global Interferon Alpha-2b Biosimilar market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Bevacizumab Biosimilar market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Biosimilar and Biologics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The Biosimilar Development Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Retinal Biosimilars market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
